دورية أكاديمية
1202P Final analysis of TENEC trial: A phase II trial of temozolomide (TMZ) as second-line treatment for advanced neuroendocrine carcinomas (NEC) in patients (pts) with a poor performance status (PS)
| العنوان: | 1202P Final analysis of TENEC trial: A phase II trial of temozolomide (TMZ) as second-line treatment for advanced neuroendocrine carcinomas (NEC) in patients (pts) with a poor performance status (PS) |
|---|---|
| المؤلفون: | von Arx, C., Cannella, L., Marretta, A.L., Bracigliano, A., Tatangelo, F., Clemente, O., Iervolino, D., Granata, V., Mocerino, C., Modica, R., Pizzolorusso, A., Bianco, A., Picozzi, F., Di Sarno, A., Tafuto, S. |
| المصدر: | Annals of Oncology ; volume 34, page S708-S709 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2023.09.735 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2023.09.735Test https://api.elsevier.com/content/article/PII:S0923753423015715?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753423015715?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.6024B1A8 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2023.09.735 |
|---|